SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-21-014025
Filing Date
2021-06-10
Accepted
2021-06-10 16:20:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 43565
  Complete submission text file 0001493152-21-014025.txt   45030
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Subject) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-36989 | Film No.: 211008320
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACACIA RESEARCH CORPORATION 500 NEWPORT CENTER DRIVE, 7TH FLOOR NEWPORT BEACH CA 92660
Business Address
KUMAR AMIT (Filed by) CIK: 0001191905 (see all company filings)

Type: SC 13D/A